CHINARES PHARMA Keeps Outstanding Shares Flat at 6.28 Billion in May 2026, Affirms Public Float Compliance

Bulletin Express06-01

China Resources Pharmaceutical Group Limited (CHINARES PHARMA) filed its Monthly Return for Equity Issuer for the period ended 31 May 2026, confirming stable capital metrics and adherence to Hong Kong listing requirements.

Key highlights:

1. Issued Share Capital • Ordinary shares in issue (excluding treasury shares) stood unchanged at 6.28 billion. • The company held no treasury shares, leaving total issued share count likewise at 6.28 billion. • No new shares were issued, cancelled, or repurchased during the month.

2. Public Float • Management confirmed compliance with the Main Board’s minimum public-float threshold of 25% as at 31 May 2026.

3. Equity Incentives • The Share Option Scheme reported zero outstanding options; however, the mandate still allows up to 628.45 million shares to be issued upon future option grants and exercises. No options were exercised in May, and no funds were raised from option exercises.

4. Other Instruments and Movements • The filing recorded no warrants, convertibles, other share-issuance arrangements, or additional share movements.

The unchanged share base, absence of treasury stock, and verified public-float sufficiency underscore a stable capital structure for CHINARES PHARMA at the May 2026 month-end reporting date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1112789019?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 17:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112789019","market":"hk","top_or_hot":-1,"title":"CHINARES PHARMA Keeps Outstanding Shares Flat at 6.28 Billion in May 2026, Affirms Public Float Compliance","media":"Bulletin Express","content":"<p>China Resources Pharmaceutical Group Limited (CHINARES PHARMA) filed its Monthly Return for Equity Issuer for the period ended 31 May 2026, confirming stable capital metrics and adherence to Hong Kong listing requirements.</p>\n<p>Key highlights:</p>\n<p>1. Issued Share Capital  \n• Ordinary shares in issue (excluding treasury shares) stood unchanged at 6.28 billion.  \n• The company held no treasury shares, leaving total issued share count likewise at 6.28 billion.  \n• No new shares were issued, cancelled, or repurchased during the month.</p>\n<p>2. Public Float  \n• Management confirmed compliance with the Main Board’s minimum public-float threshold of 25% as at 31 May 2026.</p>\n<p>3. Equity Incentives  \n• The Share Option Scheme reported zero outstanding options; however, the mandate still allows up to 628.45 million shares to be issued upon future option grants and exercises. No options were exercised in May, and no funds were raised from option exercises.</p>\n<p>4. Other Instruments and Movements  \n• The filing recorded no warrants, convertibles, other share-issuance arrangements, or additional share movements.</p>\n<p>The unchanged share base, absence of treasury stock, and verified public-float sufficiency underscore a stable capital structure for CHINARES PHARMA at the May 2026 month-end reporting date.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CHINARES PHARMA Keeps Outstanding Shares Flat at 6.28 Billion in May 2026, Affirms Public Float Compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCHINARES PHARMA Keeps Outstanding Shares Flat at 6.28 Billion in May 2026, Affirms Public Float Compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-01 17:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Resources Pharmaceutical Group Limited (CHINARES PHARMA) filed its Monthly Return for Equity Issuer for the period ended 31 May 2026, confirming stable capital metrics and adherence to Hong Kong listing requirements.</p>\n<p>Key highlights:</p>\n<p>1. Issued Share Capital  \n• Ordinary shares in issue (excluding treasury shares) stood unchanged at 6.28 billion.  \n• The company held no treasury shares, leaving total issued share count likewise at 6.28 billion.  \n• No new shares were issued, cancelled, or repurchased during the month.</p>\n<p>2. Public Float  \n• Management confirmed compliance with the Main Board’s minimum public-float threshold of 25% as at 31 May 2026.</p>\n<p>3. Equity Incentives  \n• The Share Option Scheme reported zero outstanding options; however, the mandate still allows up to 628.45 million shares to be issued upon future option grants and exercises. No options were exercised in May, and no funds were raised from option exercises.</p>\n<p>4. Other Instruments and Movements  \n• The filing recorded no warrants, convertibles, other share-issuance arrangements, or additional share movements.</p>\n<p>The unchanged share base, absence of treasury stock, and verified public-float sufficiency underscore a stable capital structure for CHINARES PHARMA at the May 2026 month-end reporting date.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03320","symbol_name":"华润医药","start_time":0,"source_url":"","article_id":"1112789019","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112789019","pubTimestamp":1780304796,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Resources Pharmaceutical Group Limited (CHINARES PHARMA) filed its Monthly Return for Equity Issuer for the period ended 31 May 2026, confirming stable capital metrics and adherence to Hong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03320":"华润医药"},"translate_title":"CHINARES PHARMA于2026年5月将流通股维持在62.8亿股，确认公众持股量合规性","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":1},"content_text":"China Resources Pharmaceutical Group Limited (CHINARES PHARMA) filed its Monthly Return for Equity Issuer for the period ended 31 May 2026, confirming stable capital metrics and adherence to Hong Kong listing requirements.\nKey highlights:\n1. Issued Share Capital  \n• Ordinary shares in issue (excluding treasury shares) stood unchanged at 6.28 billion.  \n• The company held no treasury shares, leaving total issued share count likewise at 6.28 billion.  \n• No new shares were issued, cancelled, or repurchased during the month.\n2. Public Float  \n• Management confirmed compliance with the Main Board’s minimum public-float threshold of 25% as at 31 May 2026.\n3. Equity Incentives  \n• The Share Option Scheme reported zero outstanding options; however, the mandate still allows up to 628.45 million shares to be issued upon future option grants and exercises. No options were exercised in May, and no funds were raised from option exercises.\n4. Other Instruments and Movements  \n• The filing recorded no warrants, convertibles, other share-issuance arrangements, or additional share movements.\nThe unchanged share base, absence of treasury stock, and verified public-float sufficiency underscore a stable capital structure for CHINARES PHARMA at the May 2026 month-end reporting date.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1112789019","isCrawlerRequest":true}